Header Logo

Sefer Gezer

Concepts (155)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Myelodysplastic Syndromes
15
2004
32
0.610
Why?
Antiphospholipid Syndrome
1
2003
5
0.230
Why?
Bone Marrow
10
2001
80
0.210
Why?
Apoptosis
8
1999
195
0.190
Why?
Thrombosis
1
2021
52
0.180
Why?
Thalidomide
3
2004
6
0.160
Why?
Tumor Necrosis Factor-alpha
4
2004
186
0.130
Why?
Leukemia, Myeloid, Acute
4
2001
49
0.130
Why?
Antineoplastic Agents
3
2004
177
0.120
Why?
Leukemia, Promyelocytic, Acute
2
1998
4
0.120
Why?
Tretinoin
2
1998
14
0.120
Why?
Interphase
4
1990
5
0.110
Why?
Blood Coagulation
1
2011
17
0.090
Why?
Genetic Testing
1
2011
52
0.090
Why?
Cytokines
4
2001
226
0.090
Why?
Venous Thrombosis
1
2011
44
0.090
Why?
Pulmonary Embolism
1
2011
61
0.090
Why?
Hematopoietic Stem Cells
4
1999
11
0.080
Why?
Humans
26
2021
26286
0.080
Why?
Biomarkers
2
2011
556
0.080
Why?
Antineoplastic Combined Chemotherapy Protocols
2
2000
224
0.080
Why?
Lymphohistiocytosis, Hemophagocytic
1
2008
9
0.080
Why?
Male
13
2011
14162
0.070
Why?
Cell Cycle
3
1997
33
0.060
Why?
Bromodeoxyuridine
3
1997
8
0.060
Why?
Antibodies, Monoclonal
2
2004
192
0.060
Why?
Female
11
2011
14539
0.060
Why?
Proto-Oncogenes
1
2004
4
0.060
Why?
Arsenicals
1
2004
11
0.060
Why?
Oxides
1
2004
15
0.060
Why?
Immunosuppressive Agents
2
2004
124
0.060
Why?
Aged
11
2011
8765
0.060
Why?
Drug Resistance, Neoplasm
1
2004
62
0.060
Why?
Pilot Projects
4
2011
378
0.060
Why?
Transcription Factors
1
2004
159
0.050
Why?
Arthroplasty, Replacement, Knee
1
2011
615
0.050
Why?
Transforming Growth Factor beta
3
2001
92
0.050
Why?
DNA-Binding Proteins
1
2004
254
0.050
Why?
Middle Aged
10
2011
8601
0.050
Why?
Aged, 80 and over
7
2011
4675
0.050
Why?
Prevalence
1
2003
437
0.050
Why?
Cytarabine
3
2001
11
0.050
Why?
Adult
6
2021
7448
0.050
Why?
Bone Marrow Cells
1
2001
50
0.050
Why?
Blood Transfusion
1
2001
65
0.050
Why?
DNA, Neoplasm
2
1998
16
0.040
Why?
Anemia
1
2001
93
0.040
Why?
Connective Tissue
2
1996
21
0.040
Why?
Palliative Care
1
2000
103
0.040
Why?
Cytogenetic Analysis
3
2004
5
0.040
Why?
Remission Induction
3
2004
89
0.040
Why?
Hematopoiesis
4
2001
11
0.040
Why?
Ecchymosis
1
1998
2
0.040
Why?
Cell Division
4
2001
79
0.040
Why?
Severity of Illness Index
1
2021
936
0.040
Why?
Idoxuridine
1
1997
1
0.040
Why?
Cell Lineage
3
2004
23
0.040
Why?
Granulocyte-Macrophage Colony-Stimulating Factor
1
1996
10
0.030
Why?
Cysteine Endopeptidases
1
1996
5
0.030
Why?
Endopeptidases
1
1996
15
0.030
Why?
Leukemia, Myeloid
2
1995
4
0.030
Why?
DNA
3
1997
93
0.030
Why?
Treatment Outcome
5
2004
3391
0.030
Why?
Macrophages
3
2001
105
0.030
Why?
Tumor Cells, Cultured
2
1992
116
0.030
Why?
Phenotype
2
2011
290
0.030
Why?
Risk Factors
2
2011
2265
0.020
Why?
Time Factors
2
2001
1391
0.020
Why?
Hemoglobins
2
2001
75
0.020
Why?
Mitoxantrone
2
2001
4
0.020
Why?
Blood Cell Count
2
2001
12
0.020
Why?
Pedigree
1
2011
55
0.020
Why?
Chi-Square Distribution
1
2011
134
0.020
Why?
Amifostine
2
2000
3
0.020
Why?
Monosomy
1
1990
1
0.020
Why?
Leukemia, Monocytic, Acute
1
1990
3
0.020
Why?
Preoperative Care
1
2011
122
0.020
Why?
Chromosome Deletion
1
1990
16
0.020
Why?
Anticoagulants
1
2011
89
0.020
Why?
Case-Control Studies
2
2001
566
0.020
Why?
Antigens, CD34
2
2001
11
0.020
Why?
Patient Selection
1
2011
194
0.020
Why?
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
1
1989
8
0.020
Why?
Antigens, Neoplasm
1
1989
38
0.020
Why?
Nucleoproteins
1
1988
2
0.020
Why?
Superoxides
1
1988
26
0.020
Why?
Genetic Predisposition to Disease
1
2011
374
0.020
Why?
Fatal Outcome
1
2008
52
0.020
Why?
Disease Progression
2
2004
687
0.020
Why?
Cell Differentiation
1
1988
124
0.020
Why?
Risk Assessment
1
2011
629
0.020
Why?
Chicago
1
2011
843
0.020
Why?
DNA Fragmentation
2
1996
5
0.020
Why?
DNA Replication
2
1996
10
0.020
Why?
S Phase
2
1999
8
0.020
Why?
Interleukin-1
2
1996
46
0.020
Why?
Surveys and Questionnaires
1
2011
1074
0.020
Why?
Anemia, Refractory
1
2004
1
0.020
Why?
Pancytopenia
1
2004
2
0.020
Why?
Chromosome Aberrations
1
2004
13
0.020
Why?
Infliximab
1
2004
16
0.010
Why?
MDS1 and EVI1 Complex Locus Protein
1
2004
3
0.010
Why?
Zinc Fingers
1
2004
12
0.010
Why?
Spleen
1
2004
31
0.010
Why?
Reverse Transcriptase Polymerase Chain Reaction
1
2004
119
0.010
Why?
Drug Therapy, Combination
1
2004
170
0.010
Why?
Patient Compliance
1
2004
145
0.010
Why?
Acute Disease
2
1995
192
0.010
Why?
Lymphokines
1
2001
8
0.010
Why?
Platelet Count
1
2001
15
0.010
Why?
Transforming Growth Factor alpha
1
2001
8
0.010
Why?
Vascular Endothelial Growth Factors
1
2001
13
0.010
Why?
Endothelial Growth Factors
1
2001
9
0.010
Why?
Coculture Techniques
1
2001
27
0.010
Why?
Fetal Blood
1
2001
13
0.010
Why?
Adipocytes
1
2001
12
0.010
Why?
Endothelium
1
2001
11
0.010
Why?
Microscopy, Electron
1
2001
65
0.010
Why?
Cell Culture Techniques
1
2001
31
0.010
Why?
Maximum Tolerated Dose
1
2001
13
0.010
Why?
Fibroblasts
1
2001
57
0.010
Why?
Stromal Cells
1
2001
31
0.010
Why?
Vascular Endothelial Growth Factor A
1
2001
66
0.010
Why?
Drug Administration Schedule
1
2001
156
0.010
Why?
Immunohistochemistry
1
2001
338
0.010
Why?
Radiation-Protective Agents
1
2000
4
0.010
Why?
Anorexia
1
2000
2
0.010
Why?
Pentoxifylline
1
2000
6
0.010
Why?
Ciprofloxacin
1
2000
12
0.010
Why?
Hematologic Diseases
1
2000
11
0.010
Why?
Hypotension
1
2000
28
0.010
Why?
Dexamethasone
1
2000
32
0.010
Why?
Gastrointestinal Diseases
1
2000
35
0.010
Why?
Karyotyping
1
1999
8
0.010
Why?
In Situ Nick-End Labeling
1
1999
14
0.010
Why?
Age Factors
1
2001
753
0.010
Why?
Prognosis
1
2000
758
0.010
Why?
Sialoglycoproteins
1
1996
9
0.010
Why?
Cysteine Proteinase Inhibitors
1
1996
6
0.010
Why?
Interleukin 1 Receptor Antagonist Protein
1
1996
13
0.010
Why?
Oligopeptides
1
1996
22
0.010
Why?
Caspase 1
1
1996
16
0.010
Why?
Diagnosis, Differential
1
1998
347
0.010
Why?
Leukemia
1
1996
4
0.010
Why?
Lymphoma, Non-Hodgkin
1
1996
37
0.010
Why?
Cohort Studies
1
2001
1838
0.010
Why?
Biopsy
1
1995
200
0.010
Why?
Models, Biological
1
1996
306
0.010
Why?
Adolescent
1
1999
2080
0.010
Why?
Tritium
1
1992
7
0.010
Why?
Dose-Response Relationship, Drug
1
1992
323
0.010
Why?
Metaphase
1
1990
2
0.010
Why?
Nucleic Acid Hybridization
1
1990
7
0.010
Why?
Chromosome Mapping
1
1990
26
0.010
Why?
Regeneration
1
1989
20
0.000
Why?
Gezer's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (155)
Explore
_
Co-Authors (6)
Explore
_
Similar People (60)
Explore
_
Same Department Expand Description
Explore
_